Data as of Friday, October 23, 2026From 500 companies’ SEC filings · refreshed twice a day · Send feedback
Companies / Health Care / Health Care Equipment

ResMed stock buybacks

RMD
$700Mbought back in the 12 months to Jun 30, 2026

ResMed bought back $700M of its stock in the last twelve months, $596M more than it paid out in stock compensation. Its share count is down 1.3% from a year earlier.

Stock repurchases by quarter
$0$100M$200MQ3 '20Q3 '21Q3 '22Q3 '23Q3 '24Q2 '26
Show as table
PeriodValue
Q3 '20$0
Q4 '20$0
Q1 '21$0
Q2 '21$0
Q3 '21$0
Q4 '21$0
Q1 '22$0
Q2 '22$0
Q3 '22$0
Q4 '22$0
Q1 '23$0
Q2 '23$0
Q3 '23$0
Q4 '23$50.0M
Q1 '24$50M
Q2 '24$50M
Q3 '24$50.0M
Q4 '24$75.0M
Q1 '25$75.0M
Q2 '25$100.0M
Q3 '25$150.0M
Q4 '25$175.0M
Q1 '26$175.0M
Q2 '26$200M
Diluted shares outstanding
145.3M146.6M147.8MQ3 '20Q3 '21Q3 '22Q3 '23Q3 '24Q3 '25Q2 '26
Show as table
PeriodValue
Q3 '20146.1M
Q4 '20146.4M
Q1 '21145.5M
Q2 '21147.8M
Q3 '21146.9M
Q4 '21147.0M
Q1 '22147.0M
Q2 '22147.3M
Q3 '22147.1M
Q4 '22147.4M
Q1 '23147.4M
Q2 '23147.9M
Q3 '23147.5M
Q4 '23147.5M
Q1 '24147.4M
Q2 '24147.7M
Q3 '24147.6M
Q4 '24147.5M
Q1 '25147.2M
Q2 '25147.1M
Q3 '25146.9M
Q4 '25146.4M
Q1 '26145.7M
Q2 '26145.2M
$200Mlast quarter (Q2 2026)
$596Mnet of stock compensation ($104M)
−1.3%diluted shares, 1 year
−0.3%diluted shares, 5 years
$350Mdividends, 12 months
42%of free cash flow ($1.6B) spent on buybacks
$75Mraised by issuing stock, 12 months
144.3Mshares outstanding (Aug 10, 2026)

By fiscal year

Fiscal yearBuybacksDividendsStock payFree cash flowDiluted sharesFiling
2026$700M$350M$104M$1.6B146.1M10-K
2025$300M$311M$92M$1.7B147.3M10-K
2024$150M$282M$80M$1.3B147.6M10-K
2023$0$258M$71M$574M147.5M10-K
2022$0$245M$65M$216M147.0M10-K
2019$23M$212M$52M$390M144.5M10-K
2018$54M$199M$48M$442M144.0M10-K
2016$102M$168M$46M$489M141.7M10-K
2015$160M$157M$48M—142.7M10-K
2014$202M$142M$43M—144.4M10-K

Questions

Does ResMed buy back its stock?
ResMed bought back $700M of its stock in the last twelve months, $596M more than it paid out in stock compensation. Its share count is down 1.3% from a year earlier.
How much did ResMed spend on buybacks in fiscal 2026?
$700M, according to its 10-K for the fiscal year ending Jun 30, 2026.
Is ResMed's share count going down?
Its diluted share count changed −0.3% over five fiscal years and −1.3% over the last year.

Latest filing used: 10-K for the period ending Jun 30, 2026, filed Aug 13, 2026 · open on SEC.gov

Other Health Care companies